Aytu Biopharma (AYTU) Inventory (2015 - 2026)

Aytu Biopharma (AYTU) has 12 years of Inventory data on file, last reported at $7.5 million in Q1 2026.

• On a quarterly basis, Inventory fell 32.54% year-over-year to $7.5 million in Q1 2026; TTM through Mar 2026 was $7.5 million, a 32.54% decrease from a year earlier, with the FY2025 full-year figure at $11.4 million, down 5.82% from the prior year.
• Inventory for Q1 2026 stood at $7.5 million, down from $8.7 million in the prior quarter.
• Over the last five years, Inventory for AYTU reached as high as $13.9 million in Q1 2022 and fell as low as $7.5 million in Q1 2026.
• Historically, Inventory has averaged $11.7 million across 5 years, with a median of $12.0 million in 2023.
• Across the five-year window, Inventory sank 33.6% in 2022 and advanced 10.56% in 2023, its largest moves.
• Year by year, Inventory stood at $13.0 million in 2022, then increased by 0.39% to $13.0 million in 2023, then dropped by 14.74% to $11.1 million in 2024, then dropped by 21.91% to $8.7 million in 2025, then dropped by 13.82% to $7.5 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $7.5 million in Q1 2026, $8.7 million in Q4 2025, and $10.1 million in Q3 2025.